Xoma licenses antibody technology to Pfizer (PharmaBiz)
Xoma licenses antibody technology to Pfizer (PharmaBiz)
Xoma Ltd. announced that it has licensed to Pfizer Inc., the world’s largest research-based biomedical and pharmaceutical company, non-exclusive, worldwide rights to Xoma’s patented bacterial cell expression (BCE) technology for phage display and other research, development and manufacturing of antibody products.